Role of Gut Microbiome and Intermittent Fasting in the Treatment of Obesity

doi:10.12114/j.issn.1007-9572.2019.00.452

Abstract

Abstract: Obesity and obesity-related metabolic diseases have become killers threatening human health.Recent studies have shown that obesity has a close relationship with gut microbiome，gut microbiome imbalance and lower intestinal barrier function of host can cause abnormal lipid metabolism，which triggers obesity and obesity-induced metabolic disorders.Diet is the main factor affecting gut microbiome，and unreasonable dietary structure leads to gut microbiome imbalance.A number of studies have shown that intermittent fasting can reshape gut microbiome and significantly alleviate metabolic syndrome such as obesity，which is of great significance to human health.This article elaborates the role of gut microbiome and intermittent fasting in the treatment of obesity，and points out that the combination of gut microbiome and intermittent fasting may promote clinical application of obesity research achievements.

Key words: Enterobacteriaceae, Fasting, Obesity, Caloric restriction

摘要： 肥胖及其相关代谢性疾病已经成为威胁人类健康的杀手，近年来的研究表明，肥胖与肠道菌群有着密切的关系，肠道菌群失调及宿主肠屏障功能降低会引起脂代谢异常，进而触发肥胖并引发代谢损伤。饮食是影响肠道菌群的主要因素，不合理的膳食结构会导致肠道菌群失调。多项研究表明，通过间歇性禁食来重塑肠道菌群，可显著改善肥胖等代谢综合征，对人类健康具有重要意义。本文阐述了肠道菌群在间歇性禁食治疗肥胖中的作用，并提出了在肥胖的研究中，或可通过肠道菌群与间歇性禁食二者结合研究来促进临床转化的观点。

关键词: 肠杆菌科, 禁食, 肥胖症, 热量限制

WANG Junyu,ZHANG Anren. Role of Gut Microbiome and Intermittent Fasting in the Treatment of Obesity　[J]. Chinese General Practice, 2019, 22(27): 3308-3311. DOI: 10.12114/j.issn.1007-9572.2019.00.452.
汪俊宇,张安仁. 肠道菌群在间歇性禁食治疗肥胖中的作用研究[J]. 中国全科医学, 2019, 22(27): 3308-3311. DOI: 10.12114/j.issn.1007-9572.2019.00.452.

References

［1］KOMAROFF A L.The microbiome and risk for obesity and diabetes［J］．JAMA，2017，317（4）：355-356．DOI：10.1001/jama.2016.20099.
［2］LE CHATELIER E，NIELSEN T，QIN J J，et al．Richness of human gut microbiome correlates with metabolic markers［J］．Nature，2013，500（7464）：541-546．DOI：10.1038/nature12506.
［3］HUTCHISON A T，LIU B，WOOD R E，et al．Effects of intermittent versus continuous energy intakes on insulin sensitivity and metabolic risk in women with overweight［J］．Obesity （Silver Spring），2019，27（1）：50-58．DOI：10.1002/oby.22345.
［4］LI G L，XIE C，LU S Y，et al．Intermittent fasting promotes white adipose browning and decreases obesity by shaping the gut microbiota［J］．Cell Metab，2017，26（5）：801．DOI：10.1016/j.cmet.2017.10.007.
［5］TREPANOWSKI J F，KROEGER C M，BARNOSKY A，et al．Effect of alternate-day fasting on weight loss，weight maintenance，and cardioprotection among metabolically healthy obese adults：a randomized clinical trial［J］．JAMA Intern Med，2017，177（7）：930-938．DOI：10.1001/jamainternmed.2017.0936.
［6］SAVAGE D C.Microbial ecology of the gastrointestinal tract［J］．Annu Rev Microbiol，1977，31：107-133．DOI：10.1146/annurev.mi.31.100177.000543.
［7］B?CKHED F，LEY R E，SONNENBURG J L，et al．Host-bacterial mutualism in the human intestine［J］．Science，2005，307（5717）：1915-1920．DOI：10.1126/science.1104816.
［8］ROUND J L，MAZMANIAN S K.The gut microbiota shapes intestinal immune responses during health and disease［J］．Nat Rev Immunol，2009，9（5）：313-323．DOI：10.1038/nri2515.
［9］HOOPER L V，LITTMAN D R，MACPHERSON A J.Interactions between the microbiota and the immune system［J］．Science，2012，336（6086）：1268-1273．DOI：10.1126/science.1223490.
［10］NICHOLSON J K，HOLMES E，KINROSS J，et al．Host-gut microbiota metabolic interactions［J］．Science，2012，336（6086）：1262-1267．DOI：10.1126/science.1223813.
［11］WALKER A W，PARKHILL J.Microbiology.Fighting obesity with bacteria［J］．Science，2013，341（6150）：1069-1070．DOI：10.1126/science.1243787.
［12］TURNBAUGH P J，LEY R E，MAHOWALD M A，et al．An obesity-associated gut microbiome with increased capacity for energy harvest［J］．Nature，2006，444（7122）：1027-1031．DOI：10.1038/nature05414.
［13］THAISS C A，ITAV S，ROTHSCHILD D，et al．Persistent microbiome alterations modulate the rate of post-dieting weight regain［J］．Nature，2016，540（7634）：544-551．DOI：10.1038/nature20796.
［14］FONTANA L，PARTRIDGE L.Promoting health and longevity through diet：from model organisms to humans［J］．Cell，2015，161（1）：106-118．DOI：10.1016/j.cell.2015.02.020.
［15］CATENACCI V A，PAN Z X，OSTENDORF D，et al．A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity［J］．Obesity （Silver Spring），2016，24（9）：1874-1883．DOI：10.1002/oby.21581.
［16］HODDY K K，KROEGER C M，TREPANOWSKI J F，et al．Meal timing during alternate day fasting：impact on body weight and cardiovascular disease risk in obese adults［J］．Obesity （Silver Spring），2014，22（12）：2524-2531．DOI：10.1002/oby.20909.
［17］CARTER S，CLIFTON P M，KEOGH J B.The effects of intermittent compared to continuous energy restriction on glycaemic control in type 2 diabetes；a pragmatic pilot trial［J］．Diabetes Res Clin Pract，2016，122：106-112．DOI：10.1016/j.diabres.2016.10.010.
［18］SUTTON E F，BEYL R，EARLY K S，et al．Early time-restricted feeding improves insulin sensitivity，blood pressure，and oxidative stress even without weight loss in men with prediabetes［J］．Cell Metab，2018，27（6）：1212-1221.e3．DOI：10.1016/j.cmet.2018.04.010.
［19］MARTINEZ-LOPEZ N，TARABRA E，TOLEDO M，et al．System-wide benefits of intermeal fasting by autophagy［J］．Cell Metab，2017，26（6）：856-871．DOI：10.1016/j.cmet.2017.09.020.
［20］容祖华，梁少聪，路浚齐，等．间歇性断食对老年前期肥胖大鼠肠道菌群及代谢的影响［J］．南方医科大学学报，2017，37（4）：423-430．DOI：10.3969/j.issn.1673-4254.2017.04.01.　
［21］WANG S，HUANG M Q，YOU X，et al．Gut microbiota mediates the anti-obesity effect of calorie restriction in mice［J］．Sci Rep，2018，8（1）：13037．DOI：10.1038/s41598-018-31353-1.
［22］GOMEZ A，PETRZELKOVA K J，BURNS M B，et al．Gut microbiome of coexisting BaAka pygmies and bantu reflects gradients of traditional subsistence patterns［J］．Cell Rep，2016，14（9）：2142-2153．DOI：10.1016/j.celrep.2016.02.013.
［23］DANIEL H，GHOLAMI A M，BERRY D，et al．High-fat diet alters gut microbiota physiology in mice［J］．ISME J，2014，8（2）：295-308．DOI：10.1038/ismej.2013.155.
［24］DE ANGELIS M，MONTEMURNO E，VANNINI L，et al．Effect of whole-grain barley on the human fecal microbiota and metabolome［J］．Appl Environ Microbiol，2015，81（22）：7945-7956．DOI：10.1128/AEM.02507-15.
［25］DAVID L A，MAURICE C F，CARMODY R N，et al．Diet rapidly and reproducibly alters the human gut microbiome［J］．Nature，2014，505（7484）：559-563．DOI：10.1038/nature12820.
［26］FABBIANO S，SUáREZ-ZAMORANO N，CHEVALIER C，et al．Functional gut microbiota remodeling contributes to the caloric restriction-induced metabolic improvements［J］．Cell Metab，2018，28（6）：907-921.e7．DOI：10.1016/j.cmet.2018.08.005.
［27］DUSZKA K，ELLERO-SIMATOS S，OW G S，et al．Complementary intestinal mucosa and microbiota responses to caloric restriction［J］．Sci Rep，2018，8（1）：11338．DOI：10.1038/s41598-018-29815-7.
［28］ZARRINPAR A，CHAIX A，YOOSEPH S，et al．Diet and feeding pattern affect the diurnal dynamics of the gut microbiome［J］．Cell Metab，2014，20（6）：1006-1017．DOI：10.1016/j.cmet.2014.11.008.
［29］CHEN Y T，YANG N S，LIN Y C，et al．A combination of Lactobacillus Mali APS1 and dieting improved the efficacy of obesity treatment via manipulating gut microbiome in mice［J］．Sci Rep，2018，8（1）：6153．DOI：10.1038/s41598-018-23844-y.
［30］KOOTTE R S，LEVIN E，SALOJ?RVI J，et al．Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition［J］．Cell Metab，2017，26（4）：611-619.e6．DOI：10.1016/j.cmet.2017.09.008.
［31］ALLEGRETTI J R，KAO D N，SITKO J，et al．Early antibiotic use after fecal microbiota transplantation increases risk of treatment failure［J］．Clin Infect Dis，2018，66（1）：134-135．DOI：10.1093/cid/cix684.
［32］JUUL F E，GARBORG K，BRETTHAUER M，et al．Fecal microbiota transplantation for primary clostridium difficile infection［J］．N Engl J Med，2018，378（26）：2535-2536．DOI：10.1056/NEJMc1803103.
［33］ZHANG T，XIANG J，CUI B T，et al．Cost-effectiveness analysis of fecal microbiota transplantation for inflammatory bowel disease［J］．Oncotarget，2017，8（51）：88894-88903．DOI：10.18632/oncotarget.21491.
［34］PARAMSOTHY S，KAMM M A，KAAKOUSH N O，et al．Multidonor intensive faecal microbiota transplantation for active ulcerative colitis：a randomised placebo-controlled trial［J］．Lancet，2017，389（10075）：1218-1228．DOI：10.1016/S0140-6736（17）30182-4.
［35］GE X L，TIAN H L，DING C，et al．Fecal microbiota transplantation in combination with soluble dietary fiber for treatment of slow transit constipation：a pilot study［J］．Arch Med Res，2016，47（3）：236-242．DOI：10.1016/j.arcmed.2016.06.005.
［36］HOLVOET T，JOOSSENS M，WANG J，et al．Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating［J］．Gut，2017，66（5）：980-982．DOI：10.1136/gutjnl-2016-312513.
［37］HOYLES L，FERNáNDEZ-REAL J M，FEDERICI M，et al．Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women［J］．Nat Med，2018，24（7）：1070-1080．DOI：10.1038/s41591-018-0061-3.

[1]	HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958.
[2]	ZHANG Ke, ZENG Xianchang, ZOLZAYA Enkhzaya, ZHU Yelin, HUANG Yiwen, LIU Zhenxiu, TAO Feng. Effect of Xiere Xingpi Yin on Eating Behaviors and Weight-related Outcomes in Patients with Obesity: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(20): 2759-2765.
[3]	REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845.
[4]	WU Zhen, XI Yaqi, HU Linlin. Characteristics of Policy Instrument Selection and Combination for Weight Management in China: a Content Analysis of National Policy Documents (2016-2025) [J]. Chinese General Practice, 2026, 29(20): 2766-2774.
[5]	CHEN Xiangyang, HUANG Hongmei, LI Sheyu. Prevention and Management of Adult Obesity: Progress and Trends from Six Keywords in 2025 [J]. Chinese General Practice, 2026, 29(20): 2753-2758.
[6]	TANG Lijuan, QI Qi, ZHANG Fan, GAO Yifu, CAO Yajing, YUE Fujuan, GAO Jinchai, LIU Xiaoli. Characterisation of the Prevalence of Overweight/Obesity among Residents Aged 18-44 Years in Hebei Province in 2013 and 2020 [J]. Chinese General Practice, 2026, 29(19): 2695-2704.
[7]	MIAO Jingjie, ZHANG Jinwen, WU Qianhao, HAN Peipei. Research Advances on the Effects of Intermittent Fasting on Cardiometabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2538-2545.
[8]	LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488.
[9]	LI Simin, ZHANG Tingting, WANG Kunbo, YANG Jianzhou, PING Weiwei. Effects of Exercise Dosage on Elderly Patients with Sarcopenia: a Meta-analysis [J]. Chinese General Practice, 2026, 29(17): 2400-2409.
[10]	Chinese Nutrition Society Obesity Prevention and Control Branch. Chinese Guidelines for Behavioral and Lifestyle Interventions for Obesity [J]. Chinese General Practice, 2026, 29(16): 2113-2139.
[11]	LI Jiali, LIU Fan, KE Lixin, LI Huijuan, WANG Haibo, ZHAO Xiaoxiao, ZHAO Xinke, LU Cuncun. Disease Burden of Obesity among Individuals Aged 60 and above Globally and in China from 1990 to 2021: Trend Analysis and Model-based Projection [J]. Chinese General Practice, 2026, 29(15): 2067-2076.
[12]	CHEN Xiaolong, JIN Jing, HUA Jialu, LI Yuyu, PAN Youjia, PAN Qi, TU Chunjing, WANG Ping. Study on the Optimal Time-use Composition of 24-hour Movement Behaviors for Obesity Prevention in College Students [J]. Chinese General Practice, 2026, 29(12): 1525-1532.
[13]	SONG Lu, LAN Zhigang, ZHOU Wei, FENG Liping, LIU Yunqiu, CHEN Shuohua, WANG Liye. Correlation Study between Diabetes Mellitus and Lung Function in Male People [J]. Chinese General Practice, 2026, 29(12): 1572-1578.
[14]	YANG Lei, GUAN Hua. Application Progress of Generative Artificial Intelligence in Weight Management [J]. Chinese General Practice, 2026, 29(12): 1533-1540.
[15]	YAN Manli, ZHANG Baoqing, HUANG Lei, LI Xiang. A New Chapter in Obesity Treatment: Mechanisms and Clinical Research Progress of Multi-target Peptide Agonists [J]. Chinese General Practice, 2026, 29(12): 1511-1519.